ARCHIVES

New Safety Concerns On ESAs Prompt FDA To Consult ODAC Again.

This article is from The Cancer Letter archive.

Vol. 34 No. 01 | January 11, 2008

Download PDF Visit The Full Archive

Related Articles

Four More Cooperative Groups Disapproved As NCI to Consider New Directions in Clinical Trials

March 28, 1986

Abstract Of Papers From ASTR Meeting

November 5, 1976

Possible Budget Balancing Effort Darkens Prospect For Increase In Cancer Budget

March 7, 1980

SEC Investigating Bristol-Myers’ Sales Statements

July 12, 2002

Richard Wood, ICRF, Accepts Appointment At Pittsburgh.

March 2, 2001

NCI To End CIS Partnership Program In 2010.

December 5, 2008